Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could targeted radiation delay cancer spread in breast cancer patients?

NCT ID NCT02089100

Ongoing Disease control Sponsor: Gustave Roussy, Cancer Campus, Grand Paris Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a highly focused type of radiation called stereotactic body radiation therapy (SBRT) can delay cancer progression in women with metastatic breast cancer who are starting their first treatment. About 154 participants will receive either standard therapy alone or standard therapy plus SBRT to their tumors. The goal is to see if adding SBRT helps keep the cancer from growing or spreading longer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

  • CHU la Timone

    Marseille, 13385, France

  • Centre Antoine Lacassagne

    Nice, 06189, France

  • Centre Eugène Marquis

    Rennes, 35042, France

  • Centre François Baclesse

    Caen, 14076, France

  • Centre Oscar Lambret

    Lille, 59020, France

  • Centre Paul Strauss

    Strasbourg, 67065, France

  • Centre de Cancérologie Paris Nord

    Sarcelles, 95200, France

  • Centre de Radiothérapie de la Robertsau

    Strasbourg, 67000, France

  • Georges François Leclerc

    Dijon, 21079, France

  • Gustave Roussy Cancer Campus Grand Paris

    Villejuif, Val de Marne, 94805, France

  • Henri Becquerel

    Rouen, 76000, France

  • Hôpital Bretonneau

    Tours, 37000, France

  • Hôpital Nord

    Marseille, 13015, France

  • ICM - Val d'Aurelle

    Montpellier, 34298, France

  • Institut Paoli Calmettes

    Marseille, 13273, France

  • Institut Sainte Catherine

    Avignon, 84918, France

  • Institut de Cancérologie de l'Ouest

    Saint-Herblain, 44805, France

  • Institut de cancérologie de l'Ouest René Gauducheau

    Saint-Herblain, 44805, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.